Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
MOMA-313 by Moma Therapeutics for Solid Tumor: Likelihood of Approval
MOMA-313 is under clinical development by Moma Therapeutics and currently in Phase I for Solid Tumor. According to GlobalData, Phase...
MOMA-313 by Moma Therapeutics for Metastatic Pancreatic Cancer: Likelihood of Approval
MOMA-313 is under clinical development by Moma Therapeutics and currently in Phase I for Metastatic Pancreatic Cancer. According to GlobalData,...
MOMA-313 by Moma Therapeutics for Metastatic Prostate Cancer: Likelihood of Approval
MOMA-313 is under clinical development by Moma Therapeutics and currently in Phase I for Metastatic Prostate Cancer. According to GlobalData,...